Top compounds associated with response to FES


Feature Type Standardized
Nominal ANOVA
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.23 6e-09
mRNA linifanib CTRPv2 pan-cancer AAC 0.22 1e-08
mRNA BX-795 GDSC1000 pan-cancer AAC 0.22 2e-08
mRNA AC220 GDSC1000 pan-cancer AAC 0.21 5e-08
mRNA regorafenib CTRPv2 pan-cancer AAC 0.22 6e-08
mRNA foretinib CTRPv2 pan-cancer AAC 0.21 7e-08
mRNA quizartinib CTRPv2 pan-cancer AAC 0.22 1e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-07
Download CSV